Toxicology of Alcohol Flashcards
1
Q
ADH pathway
A
- located mainly in the liver
- activated at lower concentrations of alcohol
- polymorphism especially in Asians
2
Q
MEOS pathway
A
- consists of P450, 3A4 most important isozyme
- inducible in chronic intoxication
- NAD+ independent, higher threshold than ADH
3
Q
MOA of fomepizole
A
- inhibits ADH
4
Q
MOA of disulfiram
A
- inhibits aldehyde dehydrogenase
5
Q
drugs that potentiate disulfirams effects
A
- metronidazole
- cefotetan
- trimethoprim
6
Q
GABA-A drugs and the effects of alchol
A
- GABA-A mimetic (benzos, barbiturates) exacerbate the effects of ethanol
- GABA-A antagonists decreases the effects
7
Q
ethanol effect on NMDA receptors
A
- decreases the ability of glutamate to open the cation channel associated the the NMDA receptor
8
Q
symptoms of mild alcohol withdrawal
A
- tremors
- anxiety
- insomnia
- starts 6-8 hours after consumption stops
9
Q
symptoms of severe alcohol withdrawal
A
- visual hallucinations
- total disorientations
- marked abnormality of vital signs
10
Q
treatment of mild withdrawal cases
A
- PO4, K, an Mg balance should be restored as soon as possible
- thiamine therapy is initiated in all cases
11
Q
treatment of severe withdrawal cases
A
- thiamine therapy
- hemodialysis and drug therapy
- long acting sedative hypnotic is administered and then tapered off (benzos are preferred)
- short acting benzos (lorazepam and oxazepam) are recommended in patients with liver problems
12
Q
three available drug therapies for alcoholism
A
- naltrexone
- acamprosate
- disulfiram
13
Q
naltrexone
A
- mu antagonist that reduces cravings and reduces relapses to either drinking or alcohol dependence
- should not be administered concurrently with disulfiram because of risk of hepatic toxicity
- patients must be opioid free before taking naltrexone
14
Q
acamprosate
A
- weak NMDA receptor antagonist
- C.I. in patients with serious renal impairment
15
Q
disulfiram
A
- causes severe discomfort in drinkers